4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-20-028034
President and CEO acquired 680,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Domzalski David · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-06 | Grant or award : show line 1 in the form | +680,000 | 1,247,213 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-05-06 | Grant or award : show line 2 in the form Stock Options | +680,000 | $1.95 | 2030-05-06 | 680,000 | 680,000 | D |
Loading xslF345X03/doc4.xml…